Global Equine Rhinopneumonitis Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Equine Rhinopneumonitis Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Equine Rhinopneumonitis Vaccine can prevent Equine Rhinopneumonitis，viruses that are prevalent in horses and can cause outbreaks of respiratory disease.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Equine Rhinopneumonitis Vaccine industry chain, the market status of Veterinary Pharmacy (Live, Inactivated), Online Sale (Live, Inactivated), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Equine Rhinopneumonitis Vaccine.

Regionally, the report analyzes the Equine Rhinopneumonitis Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Equine Rhinopneumonitis Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Equine Rhinopneumonitis Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Equine Rhinopneumonitis Vaccine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Live, Inactivated).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Equine Rhinopneumonitis Vaccine market.

Regional Analysis: The report involves examining the Equine Rhinopneumonitis Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Equine Rhinopneumonitis Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Equine Rhinopneumonitis Vaccine:
Company Analysis: Report covers individual Equine Rhinopneumonitis Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Equine Rhinopneumonitis Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Veterinary Pharmacy, Online Sale).

Technology Analysis: Report covers specific technologies relevant to Equine Rhinopneumonitis Vaccine. It assesses the current state, advancements, and potential future developments in Equine Rhinopneumonitis Vaccine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Equine Rhinopneumonitis Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Equine Rhinopneumonitis Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Live
    Inactivated

Market segment by Application
    Veterinary Pharmacy
    Online Sale
    Others

Major players covered
    Zoetis
    Nisseiken Co., Ltd.
    Boehringer Ingelheim
    Santa Cruz Animal Health
    Merck

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Equine Rhinopneumonitis Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Equine Rhinopneumonitis Vaccine, with price, sales, revenue and global market share of Equine Rhinopneumonitis Vaccine from 2019 to 2024.
Chapter 3, the Equine Rhinopneumonitis Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Rhinopneumonitis Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Equine Rhinopneumonitis Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Equine Rhinopneumonitis Vaccine.
Chapter 14 and 15, to describe Equine Rhinopneumonitis Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Equine Rhinopneumonitis Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Equine Rhinopneumonitis Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Live
        1.3.3 Inactivated
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Equine Rhinopneumonitis Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Veterinary Pharmacy
        1.4.3 Online Sale
        1.4.4 Others
    1.5 Global Equine Rhinopneumonitis Vaccine Market Size & Forecast
        1.5.1 Global Equine Rhinopneumonitis Vaccine Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Equine Rhinopneumonitis Vaccine Sales Quantity (2019-2030)
        1.5.3 Global Equine Rhinopneumonitis Vaccine Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Zoetis
        2.1.1 Zoetis Details
        2.1.2 Zoetis Major Business
        2.1.3 Zoetis Equine Rhinopneumonitis Vaccine Product and Services
        2.1.4 Zoetis Equine Rhinopneumonitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Zoetis Recent Developments/Updates
    2.2 Nisseiken Co., Ltd.
        2.2.1 Nisseiken Co., Ltd. Details
        2.2.2 Nisseiken Co., Ltd. Major Business
        2.2.3 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product and Services
        2.2.4 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Nisseiken Co., Ltd. Recent Developments/Updates
    2.3 Boehringer Ingelheim
        2.3.1 Boehringer Ingelheim Details
        2.3.2 Boehringer Ingelheim Major Business
        2.3.3 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product and Services
        2.3.4 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Boehringer Ingelheim Recent Developments/Updates
    2.4 Santa Cruz Animal Health
        2.4.1 Santa Cruz Animal Health Details
        2.4.2 Santa Cruz Animal Health Major Business
        2.4.3 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product and Services
        2.4.4 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Santa Cruz Animal Health Recent Developments/Updates
    2.5 Merck
        2.5.1 Merck Details
        2.5.2 Merck Major Business
        2.5.3 Merck Equine Rhinopneumonitis Vaccine Product and Services
        2.5.4 Merck Equine Rhinopneumonitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Merck Recent Developments/Updates

3 Competitive Environment: Equine Rhinopneumonitis Vaccine by Manufacturer
    3.1 Global Equine Rhinopneumonitis Vaccine Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Equine Rhinopneumonitis Vaccine Revenue by Manufacturer (2019-2024)
    3.3 Global Equine Rhinopneumonitis Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Equine Rhinopneumonitis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Equine Rhinopneumonitis Vaccine Manufacturer Market Share in 2023
        3.4.2 Top 6 Equine Rhinopneumonitis Vaccine Manufacturer Market Share in 2023
    3.5 Equine Rhinopneumonitis Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Equine Rhinopneumonitis Vaccine Market: Region Footprint
        3.5.2 Equine Rhinopneumonitis Vaccine Market: Company Product Type Footprint
        3.5.3 Equine Rhinopneumonitis Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Equine Rhinopneumonitis Vaccine Market Size by Region
        4.1.1 Global Equine Rhinopneumonitis Vaccine Sales Quantity by Region (2019-2030)
        4.1.2 Global Equine Rhinopneumonitis Vaccine Consumption Value by Region (2019-2030)
        4.1.3 Global Equine Rhinopneumonitis Vaccine Average Price by Region (2019-2030)
    4.2 North America Equine Rhinopneumonitis Vaccine Consumption Value (2019-2030)
    4.3 Europe Equine Rhinopneumonitis Vaccine Consumption Value (2019-2030)
    4.4 Asia-Pacific Equine Rhinopneumonitis Vaccine Consumption Value (2019-2030)
    4.5 South America Equine Rhinopneumonitis Vaccine Consumption Value (2019-2030)
    4.6 Middle East and Africa Equine Rhinopneumonitis Vaccine Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2019-2030)
    5.2 Global Equine Rhinopneumonitis Vaccine Consumption Value by Type (2019-2030)
    5.3 Global Equine Rhinopneumonitis Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2019-2030)
    6.2 Global Equine Rhinopneumonitis Vaccine Consumption Value by Application (2019-2030)
    6.3 Global Equine Rhinopneumonitis Vaccine Average Price by Application (2019-2030)

7 North America
    7.1 North America Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2019-2030)
    7.2 North America Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2019-2030)
    7.3 North America Equine Rhinopneumonitis Vaccine Market Size by Country
        7.3.1 North America Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2019-2030)
        7.3.2 North America Equine Rhinopneumonitis Vaccine Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2019-2030)
    8.2 Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2019-2030)
    8.3 Europe Equine Rhinopneumonitis Vaccine Market Size by Country
        8.3.1 Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2019-2030)
        8.3.2 Europe Equine Rhinopneumonitis Vaccine Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Equine Rhinopneumonitis Vaccine Market Size by Region
        9.3.1 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Equine Rhinopneumonitis Vaccine Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2019-2030)
    10.2 South America Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2019-2030)
    10.3 South America Equine Rhinopneumonitis Vaccine Market Size by Country
        10.3.1 South America Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2019-2030)
        10.3.2 South America Equine Rhinopneumonitis Vaccine Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Equine Rhinopneumonitis Vaccine Market Size by Country
        11.3.1 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Equine Rhinopneumonitis Vaccine Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Equine Rhinopneumonitis Vaccine Market Drivers
    12.2 Equine Rhinopneumonitis Vaccine Market Restraints
    12.3 Equine Rhinopneumonitis Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Equine Rhinopneumonitis Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Equine Rhinopneumonitis Vaccine
    13.3 Equine Rhinopneumonitis Vaccine Production Process
    13.4 Equine Rhinopneumonitis Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Equine Rhinopneumonitis Vaccine Typical Distributors
    14.3 Equine Rhinopneumonitis Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Equine Rhinopneumonitis Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Equine Rhinopneumonitis Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Zoetis Basic Information, Manufacturing Base and Competitors
    Table 4. Zoetis Major Business
    Table 5. Zoetis Equine Rhinopneumonitis Vaccine Product and Services
    Table 6. Zoetis Equine Rhinopneumonitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Zoetis Recent Developments/Updates
    Table 8. Nisseiken Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 9. Nisseiken Co., Ltd. Major Business
    Table 10. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product and Services
    Table 11. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Nisseiken Co., Ltd. Recent Developments/Updates
    Table 13. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 14. Boehringer Ingelheim Major Business
    Table 15. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product and Services
    Table 16. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Boehringer Ingelheim Recent Developments/Updates
    Table 18. Santa Cruz Animal Health Basic Information, Manufacturing Base and Competitors
    Table 19. Santa Cruz Animal Health Major Business
    Table 20. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product and Services
    Table 21. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Santa Cruz Animal Health Recent Developments/Updates
    Table 23. Merck Basic Information, Manufacturing Base and Competitors
    Table 24. Merck Major Business
    Table 25. Merck Equine Rhinopneumonitis Vaccine Product and Services
    Table 26. Merck Equine Rhinopneumonitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Merck Recent Developments/Updates
    Table 28. Global Equine Rhinopneumonitis Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 29. Global Equine Rhinopneumonitis Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 30. Global Equine Rhinopneumonitis Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 31. Market Position of Manufacturers in Equine Rhinopneumonitis Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 32. Head Office and Equine Rhinopneumonitis Vaccine Production Site of Key Manufacturer
    Table 33. Equine Rhinopneumonitis Vaccine Market: Company Product Type Footprint
    Table 34. Equine Rhinopneumonitis Vaccine Market: Company Product Application Footprint
    Table 35. Equine Rhinopneumonitis Vaccine New Market Entrants and Barriers to Market Entry
    Table 36. Equine Rhinopneumonitis Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 37. Global Equine Rhinopneumonitis Vaccine Sales Quantity by Region (2019-2024) & (K Units)
    Table 38. Global Equine Rhinopneumonitis Vaccine Sales Quantity by Region (2025-2030) & (K Units)
    Table 39. Global Equine Rhinopneumonitis Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 40. Global Equine Rhinopneumonitis Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 41. Global Equine Rhinopneumonitis Vaccine Average Price by Region (2019-2024) & (US$/Unit)
    Table 42. Global Equine Rhinopneumonitis Vaccine Average Price by Region (2025-2030) & (US$/Unit)
    Table 43. Global Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 44. Global Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 45. Global Equine Rhinopneumonitis Vaccine Consumption Value by Type (2019-2024) & (USD Million)
    Table 46. Global Equine Rhinopneumonitis Vaccine Consumption Value by Type (2025-2030) & (USD Million)
    Table 47. Global Equine Rhinopneumonitis Vaccine Average Price by Type (2019-2024) & (US$/Unit)
    Table 48. Global Equine Rhinopneumonitis Vaccine Average Price by Type (2025-2030) & (US$/Unit)
    Table 49. Global Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 50. Global Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 51. Global Equine Rhinopneumonitis Vaccine Consumption Value by Application (2019-2024) & (USD Million)
    Table 52. Global Equine Rhinopneumonitis Vaccine Consumption Value by Application (2025-2030) & (USD Million)
    Table 53. Global Equine Rhinopneumonitis Vaccine Average Price by Application (2019-2024) & (US$/Unit)
    Table 54. Global Equine Rhinopneumonitis Vaccine Average Price by Application (2025-2030) & (US$/Unit)
    Table 55. North America Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 56. North America Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 57. North America Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 58. North America Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 59. North America Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2019-2024) & (K Units)
    Table 60. North America Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2025-2030) & (K Units)
    Table 61. North America Equine Rhinopneumonitis Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 62. North America Equine Rhinopneumonitis Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 63. Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 64. Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 65. Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 66. Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 67. Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2019-2024) & (K Units)
    Table 68. Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2025-2030) & (K Units)
    Table 69. Europe Equine Rhinopneumonitis Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 70. Europe Equine Rhinopneumonitis Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 71. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 72. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 73. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 74. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 75. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Region (2019-2024) & (K Units)
    Table 76. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Region (2025-2030) & (K Units)
    Table 77. Asia-Pacific Equine Rhinopneumonitis Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 78. Asia-Pacific Equine Rhinopneumonitis Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 79. South America Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 80. South America Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 81. South America Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 82. South America Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 83. South America Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2019-2024) & (K Units)
    Table 84. South America Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2025-2030) & (K Units)
    Table 85. South America Equine Rhinopneumonitis Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 86. South America Equine Rhinopneumonitis Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 87. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2019-2024) & (K Units)
    Table 88. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2025-2030) & (K Units)
    Table 89. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2019-2024) & (K Units)
    Table 90. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2025-2030) & (K Units)
    Table 91. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Region (2019-2024) & (K Units)
    Table 92. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Region (2025-2030) & (K Units)
    Table 93. Middle East & Africa Equine Rhinopneumonitis Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 94. Middle East & Africa Equine Rhinopneumonitis Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 95. Equine Rhinopneumonitis Vaccine Raw Material
    Table 96. Key Manufacturers of Equine Rhinopneumonitis Vaccine Raw Materials
    Table 97. Equine Rhinopneumonitis Vaccine Typical Distributors
    Table 98. Equine Rhinopneumonitis Vaccine Typical Customers
List of Figures
    Figure 1. Equine Rhinopneumonitis Vaccine Picture
    Figure 2. Global Equine Rhinopneumonitis Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Type in 2023
    Figure 4. Live Examples
    Figure 5. Inactivated Examples
    Figure 6. Global Equine Rhinopneumonitis Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Application in 2023
    Figure 8. Veterinary Pharmacy Examples
    Figure 9. Online Sale Examples
    Figure 10. Others Examples
    Figure 11. Global Equine Rhinopneumonitis Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Equine Rhinopneumonitis Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Equine Rhinopneumonitis Vaccine Sales Quantity (2019-2030) & (K Units)
    Figure 14. Global Equine Rhinopneumonitis Vaccine Average Price (2019-2030) & (US$/Unit)
    Figure 15. Global Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Manufacturer in 2023
    Figure 16. Global Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Manufacturer in 2023
    Figure 17. Producer Shipments of Equine Rhinopneumonitis Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 18. Top 3 Equine Rhinopneumonitis Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Top 6 Equine Rhinopneumonitis Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 20. Global Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 21. Global Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 22. North America Equine Rhinopneumonitis Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 23. Europe Equine Rhinopneumonitis Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 24. Asia-Pacific Equine Rhinopneumonitis Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 25. South America Equine Rhinopneumonitis Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 26. Middle East & Africa Equine Rhinopneumonitis Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 27. Global Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 28. Global Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Type (2019-2030)
    Figure 29. Global Equine Rhinopneumonitis Vaccine Average Price by Type (2019-2030) & (US$/Unit)
    Figure 30. Global Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 31. Global Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Application (2019-2030)
    Figure 32. Global Equine Rhinopneumonitis Vaccine Average Price by Application (2019-2030) & (US$/Unit)
    Figure 33. North America Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 34. North America Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 35. North America Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 36. North America Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 37. United States Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Canada Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Mexico Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Europe Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 41. Europe Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 42. Europe Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 43. Europe Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 44. Germany Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. France Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. United Kingdom Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Russia Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Italy Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 50. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 51. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 52. Asia-Pacific Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 53. China Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Japan Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. Korea Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. India Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Southeast Asia Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Australia Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. South America Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 60. South America Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 61. South America Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 62. South America Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 63. Brazil Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Argentina Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 65. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 66. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 67. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 68. Middle East & Africa Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 69. Turkey Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Egypt Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. Saudi Arabia Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. South Africa Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Equine Rhinopneumonitis Vaccine Market Drivers
    Figure 74. Equine Rhinopneumonitis Vaccine Market Restraints
    Figure 75. Equine Rhinopneumonitis Vaccine Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Equine Rhinopneumonitis Vaccine in 2023
    Figure 78. Manufacturing Process Analysis of Equine Rhinopneumonitis Vaccine
    Figure 79. Equine Rhinopneumonitis Vaccine Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Companies Mentioned

Zoetis
Nisseiken Co., Ltd.
Boehringer Ingelheim
Santa Cruz Animal Health
Merck